INS and metabolic syndrome: All these studies showed a significant positive impact on cardiovascular endpoints (e.g., a significant decrease in metabolic syndrome (MetS), LDL-C, glucose intolerance, fat mass, weight, waist circumference, and fasting glucose; significantly improved body composition, insulin sensitivity, cholesterol, and inflammatory cytokines).